Eytan Ami-Ben
Ramat Gan, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Using the vesicular stomatitis virus vector (rVSV vector) platform for SARS-CoV-2 vaccine development: Phase 1/2 safety and immunogenicity of IIBR-100 in healthy adults.
Journal: Vaccine
Published: February 05, 2025
Correlations Between Oculometric Measures and Traditional Clinical Assessments in Multiple Sclerosis.
Journal: Multiple sclerosis and related disorders
Published: May 21, 2024
Corrigendum to "Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up" [Clin Microbiol Infect] 29 (7) (2023) 918-923.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: December 21, 2023
Combination Treatment of Intratumoral Vidutolimod, Radiosurgery, Nivolumab, and Ipilimumab for Microsatellite Stable Colorectal Carcinoma With Liver Metastases.
Journal: Clinical colorectal cancer
Published: July 09, 2023
Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: November 26, 2022
IOeRT in retroperitoneal sarcoma: Towards more organ preservation with comparable oncological outcomes.
Journal: Surgical oncology
Published: November 26, 2022
Resection of Recurrent Pelvic Soft Tissue Sarcoma: Is the Risk Worth the Reward?
Journal: The Journal of surgical research
Published: March 23, 2022
Phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (cKS).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 22, 2022
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors.
Journal: Cancer discovery
Published: October 18, 2021
Thyroid dysfunction and survival in cancer patients treated with immune checkpoint inhibitors: analyses from a large single tertiary cancer center database.
Journal: Acta oncologica (Stockholm, Sweden)
Published: August 11, 2021
Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer.
Journal: Nature cancer
Published: February 07, 2021
Last Updated: 09/26/2026